A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes

Status:
Completed

Trial end date:
2004-10-01

Target enrollment:

Participant gender:

The purpose of the study is to evaluate the efficacy and safety of Aricept in nursing home patients with severe Alzheimer's disease.

Phase 3

Pfizer

Donepezil